Oxford Centre for Evidence-Based Medicine

Centre for Evidence-Based Medicine (University of Oxford)

Type	Public
Established	1995
Parent institution	University of Oxford
Director	Prof. Carl Heneghan
Academic staff	25
Students	5 Full-time DPhils, 28 part-time DPhils and 75 MSc students
Location	Oxford, United Kingdom
Website	www.cebm.net

The Centre for Evidence-Based Medicine (CEBM) based at New Radcliffe House in the University of Oxford is a not-for-profit organisation dedicated to the practice, teaching and dissemination of high quality evidence-based medicine to improve healthcare in everyday clinical practice. CEBM was founded by David Sackett in 1995 and since 2010 has been led by Professor Carl Heneghan, a Clinical Epidemiologist and General Practitioner. The Centre is part of the University's Nuffield Department of Primary Care Health Sciences.

There are currently over 25 active staff and honorary members of the CEBM. Many of the active staff include other clinicians, statisticians, epidemiologists, information specialists, quantitative and qualitative researchers.

CEBM runs a Graduate School in Evidence-Based Healthcare, together with the Department of Continuing Education at the University of Oxford. The Graduate School includes a MSc in Evidence-Based Health Care and a DPhil in Evidence-Based Health Care. along with a range of short courses

Every year, CEBM organises Evidence Live, a multi-day conference focussing on developments in the area of evidence-based medicine. The conference is organised in collaboration with the British Medical Journal. Themes for the conference include Improving the Quality of Research; disentangling the Problems of Too Much and Too Little Medicine; transforming the Communication of Evidence for Better Health; training the Next Generation of Leaders and translating Evidence into Better-Quality Health Services.

CEBM has developed a widely adopted systematic hierarchy of the quality of medical research evidence, named the levels of evidence. Systematic reviews of randomized clinical trials (encompassing homogeneity) are seen as the highest possible level of evidence, as full assessment and aggregated synthesis of underlying evidence is possible.